510(k) Report

510(k) · Cleared

Cleared

Fogarty Valvulotome Model 700091

K965137510(k) TraditionalCleared Jun 4, 1997163-day reviewClass II21 CFR 870.4885

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Baxter Edwards · MGZ Valvulotome

Cleared on Jun 4, 1997 as substantially equivalent to K925283 (Intramed Laboratories, Inc., 1994) after a 163-day review. Its family tree reaches back 1 generation to 1994.

Decided
Jun 4, 1997
Review
163 days
Class
Class II
Product code
MGZ
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K925283 (1994). No later device cites it as a predicate yet.

K925283 · Valvulotome · Intramed Laboratories, Inc. · 199419901992199419961998
K925283 · Valvulotome · Intramed Laboratories, Inc. · 19940
  1. Root · 1 generation backK925283 ValvulotomeIntramed Laboratories, Inc. · 1994
  2. This deviceK965137 Fogarty Valvulotome Model 700091Baxter Edwards · 1997
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K925283ValvulotomeIntramed Laboratories, Inc.1994—
0 (this device)K965137Fogarty Valvulotome Model 700091Baxter Edwards1997—
FIG. 1 — Lineage of K965137, 1994–1997Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MGZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MGZ device

  1. #1 K260188 LimFlow Vectorscore 11.9 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K925283Valvulotome
Summary page 1
…Substantial Equivalence The Fogarty® Valvulotome is substantially equivalent to the Intramed® Valvulotome, which was cleared for marketing under premarket notification K925283. . Device Name Fogarty® Valvulotome, Model 700091 . Predicate Device The claim of substantial equivalence is based cn the fol…
Intramed Laboratories, Inc.1994—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All MGZ devices

MGZ Valvulotome: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MGZ

1in 2025

2008: 12011: 12013: 22014: 22019: 12022: 12025: 12026 (partial year): 1
2007high 2 (2013) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MGZ

Too few MGZ 510(k)s in any year since 2007 to give a median.

Recalls per year · MGZ

1in 2014

2014: 1
2007high 1 (2014) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MGZ

8in 2025

2007: 22009: 32014: 12016: 32017: 212018: 72019: 192020: 62021: 22022: 132023: 232024: 32025: 8
2007high 23 (2023) · low 0 (2008)2025

MAUDE reports naming product code MGZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—02
20081—00
20090—03
20100—00
20111—00
20120—00
20132—00
20142—11
20150—00
20160—03
20170—021
20180—07
20191—019
20200—06
20210—02
20221—013
20230—023
20240—03
20251—08
20261—0—

What is it indicated for?

The Fogarty® Valvulotome is indicated for use in veins during in situ or autologous bypass graft procedures.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K965137: Fogarty Valvulotome Model 700091.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K965137

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026